Showing all 12 results
Ivabradine HCL Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Ivabradine (as Hydrochloride) USP/Ph.Eur. 5 mg Initiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration. Ivabradine (as Hydrochloride) USP/Ph.Eur. 7.5 mg Global Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute. Excipients Lactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet) *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).
Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Perindopril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.
Active Ingredient Strength Primary Clinical Function Perindopril Erbumine Ph.Eur./USP 2 mg Initiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension. Perindopril Erbumine Ph.Eur./USP 4 mg Hypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension. Perindopril Erbumine Ph.Eur./USP 8 mg Cardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium Stearate Diluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Prasugrel Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips containing dedicated desiccants to ensure the absolute chemical stability of the highly volatile thienopyridine molecule.
Active Ingredient Strength Primary Clinical Function Prasugrel HCl INN/Ph.Eur. 5 mg Dose-Adjusted Standard: Maintenance dose strictly for vulnerable patients weighing < 60 kg or aged ≥ 75 years to minimize fatal bleeding risk. Prasugrel HCl INN/Ph.Eur. 10 mg Global Clinical Standard: Standard adult maintenance dose following a 60 mg acute loading dose in the Cath Lab. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Hypromellose / Triacetin Diluent / Superdisintegrant / Moisture-Barrier Film-Coating (Engineered specifically to prevent hydrolytic degradation and ensure ultra-fast gastric release) *Pack Sizes: 10×10 Alu-Alu Blisters or 28/30-Tablet Calendar Blisters (Optimized specifically for strict 12-month post-PCI dual-antiplatelet dispensing regimens).
RAMIPRIL & HYDROCLORTHIAZIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Rosuvastatin + Fenofibrate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer or Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive Rosuvastatin calcium salt.
Active Ingredient Strength Primary Clinical Function Rosuvastatin Calcium INN/Ph.Eur. 10 mg or 20 mg (Equivalent to Rosuvastatin base) Potent HMG-CoA Reductase inhibition for massive LDL reduction and plaque stabilization. Fenofibrate (Micronized) INN/Ph.Eur. 160 mg (or 145 mg Nanoparticle) Global Clinical Standard: PPAR-alpha agonism for severe hypertriglyceridemia and HDL elevation. Excipients Lactose Monohydrate / Sodium Lauryl Sulfate / Crospovidone / Magnesium Stearate Diluent / Surfactant / Superdisintegrant (Engineered with heavy surfactant loading to force the insoluble Fenofibrate into systemic circulation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic cardiology dispensing regimens).
Sacubutril + Valsartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive dual-molecule complex.
Active Ingredient Strength (Total Dose) Primary Clinical Function Sacubitril / Valsartan INN/Ph.Eur. 24 mg / 26 mg (50 mg Total) Starting dose for patients with severe renal impairment, hepatic impairment, or those not currently taking an ACEi/ARB. Sacubitril / Valsartan INN/Ph.Eur. 49 mg / 51 mg (100 mg Total) Standard Initiation Dose: For patients switching from standard doses of ACE inhibitors or ARBs. Sacubitril / Valsartan INN/Ph.Eur. 97 mg / 103 mg (200 mg Total) Target Maintenance Dose: Maximum adult therapy for optimal mortality reduction in heart failure. Excipients Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 14×2 or 28-Tablet Alu-Alu Blisters (Optimized specifically for strict twice-daily chronic cardiology dispensing regimens).
